EMILY LEBLANC: Open Payments
NPI 1457750366 · BOSSIER CITY, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$597 in 34 payments from 6 companies in 2025. Trend: 2023 $697 · 2024 $1,313 · 2025 $597
Food & beverage: $597
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 14 | $312 |
| ABBVIE INC. | 14 | $174 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $43 |
| Saluda Medical Americas, Inc. | 1 | $29 |
| Collegium Pharmaceutical, Inc. | 1 | $20 |
| Medtronic, Inc. | 1 | $18 |
Products named: Clinical Trial Product, QULIPTA, UBRELVY, General - Pain Management, WaveWriter Alpha Prime 16, RELISTOR, Evoke, Belbuca.
Industry payments across LA — which companies pay providers there.
